Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s162, 2023. DOI: 10.25251/skin.7.supp.162. Disponível em: https://skin.dermsquared.com/skin/article/view/2048. Acesso em: 17 may. 2025.